ArticleBiomedicines2022

Long-Term Treatment with Simvastatin Leads to Reduced Migration Capacity of Prostate Cancer Cells.

Mona Kafka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.